Xerostomiasis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Xerostomiasis, commonly known as dry mouth, is a condition characterized by a persistent reduction in salivary flow. Saliva plays a critical role in lubricating oral tissues, initiating digestion, protecting teeth from decay, and supporting the normal balance of oral microbes. When saliva production falls below normal levels (< 0.5 mL/min at rest), patients experience the uncomfortable and sometimes serious symptoms of xerostomiasis.

While anyone can develop dry mouth, it is most prevalent among:

• Older adults – up to 30 % of people over 65 report xerostomiasis symptoms (National Institute on Aging, 2022).
• Individuals taking multiple medications – polypharmacy is the leading drug‑related cause.
• People with autoimmune disorders such as Sjögren’s syndrome, systemic lupus erythematosus, or rheumatoid arthritis.
• Cancer patients who have received radiation therapy to the head‑and‑neck region.

Overall, estimates suggest that 5–10 % of the U.S. population experiences clinically significant dry mouth at some point in their lives (CDC, 2023).

Symptoms

The clinical presentation of xerostomiasis can be subtle early on, but as saliva production declines, a wider range of problems emerges.

• Oral dryness – a constant feeling of cotton‑like or sticky mouth.
• Thick or stringy saliva – saliva becomes more viscous and difficult to swallow.
• Difficulty speaking, chewing, or swallowing – especially with dry foods.
• Burning or tingling sensation on the tongue, lips, or palate.
• Altered taste – foods may taste bland, metallic, or overly sweet.
• Bad breath (halitosis) – due to reduced clearance of food debris and bacteria.
• Increased dental decay – especially root caries and rapid progression of cavities.
• Mouth sores or fissures on the inner lips and corners of the mouth (angular cheilitis).
• Dry, cracked lips and chapped oral mucosa.
• Hoarseness or sore throat – because saliva also lubricates the pharynx.
• Oral infections – candidiasis (thrush) is common when saliva is insufficient.

Causes and Risk Factors

Dry mouth is usually multifactorial. The main categories are medication‑related, disease‑related, and lifestyle or environmental factors.

Medication‑related causes

More than 400 drugs list xerostomiasis as a possible side effect. The most common groups include:

• Antihistamines and decongestants (e.g., diphenhydramine, pseudoephedrine)
• Antidepressants and antipsychotics (e.g., SSRIs, tricyclics, clozapine)
• Antihypertensives (e.g., beta‑blockers, diuretics)
• Anticholinergics used for overactive bladder or Parkinson’s disease
• Muscle relaxants and certain opioids

Disease‑related causes

• Sjögren’s syndrome – an autoimmune attack on salivary and lacrimal glands; accounts for 20–30 % of primary xerostomiasis cases.
• Diabetes mellitus – hyperglycemia can damage salivary gland tissue.
• HIV/AIDS – opportunistic infections and medications reduce salivation.
• Neurological disorders – Parkinson’s disease, multiple sclerosis, and stroke can affect autonomic control of salivation.
• Radiation therapy – doses > 50 Gy to the salivary glands frequently cause permanent damage.
• Autoimmune connective‑tissue diseases – lupus, rheumatoid arthritis.

Lifestyle & environmental risk factors

• Smoking or tobacco‑chewing – nicotine constricts blood vessels that supply salivary glands.
• Alcohol consumption – especially in excess, it is a diuretic and irritant.
• Dehydration – inadequate fluid intake, fever, vigorous exercise, or high‑altitude exposure.
>
• Mouth breathing (e.g., due to nasal obstruction or sleep apnea) accelerates oral drying.

Diagnosis

Diagnosing xerostomiasis begins with a thorough history and clinical examination, followed by objective tests when needed.

Clinical Evaluation

• Review of medication list and systemic diseases.
• Visual inspection for dryness, fissures, dental decay, and signs of infection.
• Palpation of major salivary glands (parotid, submandibular, sublingual) for tenderness or enlargement.

Objective Salivary Flow Tests

1. Unstimulated Whole Saliva Test (UWST) – Patient spits into a graduated container for 5 minutes. < 0.1 mL/min is considered severely reduced.
2. Stimulated Whole Saliva Test – Chewing paraffin wax or applying citric acid; flow < 0.7 mL/min suggests hyposalivation.
3. Sialometry – Quantifies flow from individual glands using collection devices.
4. Scintigraphy or MRI – Rarely used, reserved for complex cases or to evaluate radiation damage.

Laboratory & Ancillary Tests

• Autoantibody panels (anti‑SSA/Ro, anti‑SSB/La) for suspected Sjögren’s syndrome.
• Blood glucose/HbA1c for diabetes screening.
• Salivary pH and buffer capacity – low values correlate with higher caries risk.
• Microbial cultures if candidiasis is suspected.

Treatment Options

Management is individualized and generally follows a stepwise approach: alleviate symptoms, stimulate residual salivation, protect oral health, and address underlying causes.

Medication Review & Adjustment

• Discuss with the prescribing physician whether a drug can be tapered, switched to an alternative with less anticholinergic effect, or taken with meals to lessen oral dryness.

Saliva Substitutes & Stimulants

• Artificial saliva sprays, gels, or lozenges – contain carboxymethylcellulose, glycerin, or hydroxyethyl‑cellulose. Use 4–6 times daily as needed.
• Prescription sialogogues –
  • Pilocarpine (1–5 mg PO qid) – cholinergic agonist that stimulates muscarinic receptors in salivary glands.
  • Cevimeline (30 mg PO tid) – FDA‑approved for Sjögren’s‑related xerostomia.
  Note: contraindicated in uncontrolled asthma, narrow‑angle glaucoma, or recent myocardial infarction.
• Chewing sugar‑free gum or sucking on xylitol‑sweetened lozenges – mechanically stimulate saliva and reduce caries risk.

Oral Hygiene Measures

• Brush twice daily with fluoride toothpaste (≥ 1,450 ppm) and floss.
• Fluoride rinse or prescription high‑fluoride gel (e.g., 5,000 ppm) weekly.
• Use a neutral‑pH, alcohol‑free mouthwash (e.g., chlorhexidine 0.12 % for infection control, or fluoride mouthwashes). Avoid products containing alcohol or astringents.
• Visit dentist every 3–4 months for professional cleaning and early caries detection.

Dietary & Lifestyle Modifications

• Increase water intake to 2–3 L/day; sip frequently rather than large gulps.
• Limit caffeine, alcohol, and highly acidic foods (citrus, soda) that can exacerbate dryness.
• Choose moist, softer foods (stews, yogurt, applesauce) and avoid overly salty or dry snacks.
• Use a humidifier at night, especially in dry climates.

Procedural Interventions (selected cases)

• Botulinum toxin injections into salivary glands – paradoxically can improve xerostomia in patients with hypersalivation; not commonly used for dry mouth.
• Salivary gland acupuncture – small studies show modest symptom relief; consider as adjunct therapy.

Management of Complications

• Antifungal therapy (e.g., nystatin oral suspension) for candidiasis.
• Dental restorative treatment for early caries; use of silver‑diamine fluoride varnish.
• Palliative treatment of oral pain with topical anesthetics (e.g., lidocaine viscous).

Living with Xerostomiasis

Adapting daily routines can dramatically improve comfort and reduce long‑term oral damage.

Practical Tips

• Carry a water bottle and sip continuously; set reminders on your phone.
• Chew sugar‑free gum after meals to stimulate residual flow.
• Keep a small tube of artificial saliva in a purse, car, and at the bedside.
• Replace toothbrushes every 3 months or sooner if bristles become frayed.
• Avoid tobacco and nicotine replacement products.
• Schedule regular dental check‑ups; inform the dentist about your dry‑mouth diagnosis.
• Use a straw when drinking acidic beverages to bypass teeth.
• Consider oral moisturizers formulated for contact lens users – they often have a comforting gel base.

Emotional & Social Aspects

Dry mouth can affect speech clarity, make eating in public uncomfortable, and lower self‑esteem. Support groups—both in‑person (e.g., Sjögren’s Foundation) and online forums—provide coping strategies and reduce isolation.

Prevention

While some causes (e.g., radiation) are unavoidable, many risk factors are modifiable.

• Ask health‑care providers to review all medications annually; seek alternatives when feasible.
• Maintain optimal hydration—aim for clear or light‑yellow urine as a hydration indicator.
• Practice good oral hygiene from an early age to build protective fluoride reserves.
• Use protective shields during head‑and‑neck radiation; intensity‑modulated radiotherapy (IMRT) can spare salivary tissue.
• Control systemic diseases (diabetes, autoimmune disorders) with appropriate medical therapy.
• Quit smoking and limit alcohol consumption.

Complications

If left untreated, chronic xerostomiasis can lead to serious oral and systemic problems:

• Dental decay & tooth loss – patients with dry mouth develop caries 2–3 times faster than the general population (Mayo Clinic, 2021).
• Periodontal disease – reduced cleansing action of saliva promotes plaque buildup.
• Oral infections – candidiasis, herpes simplex reactivation, and bacterial infections.
• Difficulty swallowing (dysphagia) – increases risk of aspiration pneumonia, especially in elderly patients.
• Malnutrition – avoidance of certain foods due to discomfort may lead to inadequate nutrient intake.
• Speech articulation problems – persistent dryness can affect consonant production.
• Quality‑of‑life decline – chronic discomfort, altered taste, and social embarrassment.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Dry mouth (xerostomia).” 2021. https://www.mayoclinic.org
2. National Institute on Aging. “Oral Health and Dry Mouth.” 2022. https://www.nia.nih.gov
3. Centers for Disease Control and Prevention. “Oral Health Surveillance Report.” 2023. https://www.cdc.gov
4. American Dental Association. “Management of Xerostomia.” 2022. https://www.ada.org
5. Cleveland Clinic. “Sjogren’s Syndrome.” 2023. https://my.clevelandclinic.org
6. World Health Organization. “Guidelines for the Use of Anticholinergic Drugs.” 2021.

```